ClinConnect ClinConnect Logo
Search / Trial NCT04255186

Treatment Using 448 kHz CRMRF in Subacromial Syndrome.

Launched by UNIVERSITY OF CASTILLA-LA MANCHA · Feb 2, 2020

Trial Information

Current as of May 27, 2025

Completed

Keywords

Shoulder Pain Shoulder Impingement Syndrome Radiofrequency Treatment Electrophysical Agents

ClinConnect Summary

Shoulder pain has a high prevalence in our society, several studies estimate an annual prevalence between 5% and 47%. It is one of the main causes of musculoskeletal pain, particularly in third place, after the low back pain and neck pain.

Symptoms of pathologies of subacromial syndrome, where, regardless of origin, pain is the number one symptom for the patient, which emanates functional impairment and the impact on quality of life.

Among the non-pharmacological treatments of subacromial syndrome, a systematic review concludes that the first line of intervention should be a therapeutic e...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients between 18 and 70 years years old with diagnosis of subacromial syndrome
  • Visual Analogue Scale (VAS) less than or equal to 7.
  • Positive Neer and Hawkins test.
  • Exclusion Criteria:
  • Clinical examination compatible with complete rotator cuff tear (Drop-arm positive test)
  • Fibromyalgia
  • Adhesive capsulitis
  • Be receiving physiotherapeutic treatment or have received it previously for this pathology one month before the start of treatment.
  • Patients with alterations of thermal sensitivity.
  • * Derived from the absolute and relative contraindications of CRMRF:
  • Pacemaker
  • Thrombophlebitis
  • Pregnancy
  • Skin disorders (recent wounds or burns)

About University Of Castilla La Mancha

The University of Castilla-La Mancha is a prominent academic institution dedicated to advancing research and innovation in various fields, including health sciences. With a commitment to fostering interdisciplinary collaboration, the university engages in groundbreaking clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Its research initiatives are supported by a robust network of experts and cutting-edge facilities, positioning the university as a leading sponsor in clinical research within the region. Through its rigorous ethical standards and dedication to scientific excellence, the University of Castilla-La Mancha strives to contribute significantly to the global body of medical knowledge.

Locations

Talavera De La Reina, Toledo, Spain

Patients applied

0 patients applied

Trial Officials

Juan Avendaño-Coy, PhD

Principal Investigator

Castilla La Mancha University

Javier Aceituno-Gómez, PhD

Principal Investigator

Castilla-La Mancha Health Service

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials